Get the Stockscreener App
9.80
6.49%
-0.68
After Hours:
9.51
-0.29
-2.96%
Inmune Bio Inc Stock (INMB) Latest News
INmune Bio Inc (INMB) shows promising results - US Post News
Trading Day Review: INmune Bio Inc (INMB) Loses Momentum, Closing at 9.31 - The Dwinnex
INmune Bio, Inc. (NASDAQ:INMB) Short Interest Update - MarketBeat
Analyzing INmune Bio Inc (INMB) After Recent Trading Activity - Knox Daily
INmune Bio, Inc. (NASDAQ:INMB) Short Interest Up 7.0% in January - Defense World
Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - Insider Monkey
(INMB) Proactive Strategies - Stock Traders Daily
INmune Bio (NASDAQ:INMB) Upgraded to "Strong-Buy" at RODMAN&RENSHAW - MarketBeat
Rodman & Renshaw Begins Coverage on INmune Bio (NASDAQ:INMB) - MarketBeat
INmune Bio (NASDAQ:INMB) Stock Rating Upgraded by RODMAN&RENSHAW - Defense World
INmune Bio advances prostate cancer trial at VA Hospital By Investing.com - Investing.com South Africa
BTIG maintains INmune Bio stock Buy rating and $21 target By Investing.com - Investing.com Australia
BTIG maintains INmune Bio stock Buy rating and $21 target - MSN
INmune Bio advances prostate cancer trial at VA Hospital - Investing.com
Rodman & Renshaw sets INmune Bio stock Buy rating, $23 target - Investing.com
INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to Veterans - The Manila Times
Groundbreaking NK Cell Cancer Treatment Now Available to Veterans: Major Trial Expansion - StockTitan
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Market Highlights: Rocket Lab USA Inc (RKLB) Ends on a High Note at 31.57 - The Dwinnex
C-Suite Buy of the Week: Executive Moves from Biotech to Banking - Benzinga
INmune Bio Insiders Added US$902.6k Of Stock To Their Holdings - Simply Wall St
Mason Resources (CVE:LLG) Stock Crosses Above 200 Day Moving Average – Should You Sell? - Defense World
Flanigan’s Enterprises (NYSEAMERICAN:BDL) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next? - Defense World
Barclays PLC Boosts Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
(INMB) Investment Analysis and Advice - Stock Traders Daily
14,725 Shares in INmune Bio, Inc. (NASDAQ:INMB) Bought by Jane Street Group LLC - Defense World
Candel Therapeutics (NASDAQ:CADL) versus INmune Bio (NASDAQ:INMB) Head-To-Head Review - Defense World
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $68.09 Average Target Price from Analysts - Defense World
Praetorian PR LLC Increases Stake in INmune Bio Inc: A Strategic Move in Biotechnology - GuruFocus.com
How Do Things Look For INmune Bio Inc (NASDAQ: INMB) In The Short-Term? - Stocks Register
Analysts’ Revisions Show Improving Sentiment For Uranium Energy Corp (AMEX: UEC) - Stocks Register
How Do Things Look For Lithium Americas Corp (NewCo) (NYSE: LAC) In The Short-Term? - Stocks Register
What Did We Note About Insider Trading At AT&T, Inc (NYSE: T)? - Stocks Register
Watch Duty was downloaded 2 million times during this week’s LA fires - Yahoo! Voices
Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28% - Yahoo Finance
Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
How To Trade (INMB) - Stock Traders Daily
Immunis Closes $25 Million Series A-1 Financing Round - Yahoo Finance
ChargePoint Holdings, Inc. (CHPT) Stock Moves -0.89%: What You Should Know - Yahoo Finance
Astera Labs, Inc. (ALAB) Stock Moves -0.82%: What You Should Know - Yahoo Finance
Palantir Technologies Inc. (PLTR) Stock Moves -1.44%: What You Should Know - Yahoo Finance
Nu Holdings Ltd. (NU) Declines More Than Market: Some Information for Investors - Yahoo Finance
IGM Bio stock plunges as analysts downgrade (IGMS:NASDAQ) - Seeking Alpha
ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock? - Yahoo Finance
Primrose Bio to Collaborate with Serum Institute of India to Develop a Novel Multi-Antigen Vaccine - Yahoo Finance
Moon Capital Management Liquidated CVS Health Corporation (CVS) with Modest Gain - Yahoo Finance
BioInvent Achieves ISO 26000 Verification, Highlighting Commitment to ESG and Transparency - Yahoo Finance
Ouro Medicines Launches to Define the Future of Treatment for People with Immune-Mediated Diseases - Yahoo Finance
Is BioLife Solutions, Inc. (NASDAQ:BLFS) Potentially Undervalued? - Yahoo Finance
January Effect Builds Up Momentum: 5 Small-Cap Stocks to Buy - Yahoo Finance
Cadenza Bio, Inc. Announces Members of the Women's Health Scientific Advisory Board - Yahoo Finance
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy - Yahoo Finance
Clipper Realty Inc. (NYSE:CLPR) Shares Purchased by Geode Capital Management LLC - Defense World
Geode Capital Management LLC Purchases 21,262 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World
Financial Survey: AIM ImmunoTech (NYSE:AIM) and INmune Bio (NASDAQ:INMB) - Defense World
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand - Yahoo Finance
Pivot Bio Announces Ryan Degnan as Head of Growth - Yahoo Finance
FluidForm Bio™ Announces Participation at Biotech Showcase and the 14th Annual LifeSci Partners Corporate Access Event - Yahoo Finance
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Kratos Defense & Security Solutions, Inc. (KTOS): A Bull Case Theory - Yahoo Finance
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):